Application of medicine in preparation of drugs for treating metastatic encephaloma and related diseases thereof
A technology of brain metastases and drugs, which is applied in the field of medicine, can solve the problems of large side effects, unsatisfactory prognosis, and inability to obtain therapeutic effects, etc., achieve strong anti-tumor, best clinical research and application value, and promote mitophagy Effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0046] This embodiment provides a drug for inhibiting brain metastases, which is a TRPV4 agonist. The TRPV4 agonist can promote the influx of calcium ions in the TRPV4 signaling channel, thereby promoting the induction of autophagy in brain tumor cells and achieving a stronger anti-brain tumor effect. The dosage of TRPV4 agonist is: the concentration is 0.01 μM-30 μM, such as 0.01 μM, 0.05 μM, 0.1 μM, 0.5 μM, 1 μM, 5 μM, 10 μM, 15 μM, 20 μM, 25 μM, 30 μM, etc.
Embodiment 2
[0048] On the basis of Example 1, the TRPV4 agonist is cannabidiol, and the concentration of the cannabidiol is 0.01 μM-30 μM, such as 0.01 μM, 0.05 μM, 0.1 μM, 0.5 μM, 1 μM, 5 μM, 10 μM, 15μM, 20μM, 25μM, 30μM, etc. Cannabidiol promotes the influx of calcium ions through the TRPV4 signaling channel, thereby promoting the induction of mitophagy in tumor cells, and finally achieving a strong anti-tumor effect.
[0049] Among them, TRPV4 (transient receptor potential channel 4) is a transient calcium ion channel. After the action of cannabidiol on TRPV4, it will cause calcium ion influx, and calcium ion influx is the main cause of activating endoplasmic reticulum stress. In the case of TRPV4 antagonists, the above-mentioned effects of cannabidiol can be reversed, so TRPV4 can be used as a potential target of cannabidiol in brain tumors.
[0050] Cannabidiol can also significantly induce the morphological changes of mitochondria, and the number of mitochondria decreases signific...
Embodiment 3
[0053] This embodiment provides a drug for inhibiting brain metastases, which includes a TRPV4 agonist and a tumor suppressor with anti-tumor activity. The concentration ratio of the TRPV4 agonist and the tumor suppressor is (that is, the case where the two concentration units are the same in the same solution): (10-30): (10-500). The mechanism of action of the TRPV4 agonist is combined with the inhibitory mechanism of the tumor inhibitor, and the combination of the two achieves the anti-tumor effect of increasing efficiency and reducing toxic and side effects.
[0054] In this embodiment, any one or more TRPV4 agonists can be used in combination with any one or more tumor suppressors.
[0055] Preferably, the tumor suppressor comprises temozolomide. The temozolomide may be used in combination with at least one TRPV4 agonist.
[0056] Preferably, the TRPV4 agonist includes cannabidiol. The TRPV4 agonist cannabidiol can be used in combination with at least one tumor suppress...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com